FMP
VolitionRx Limited
VNRX
AMEX
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
0.676 USD
0.0949 (14.04%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Cameron Reynolds MBA
sector
Healthcare
industry
Medical - Diagnostics & Research
website
https://www.volition.comexchange
AMEX
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
CIK
0000093314
ISIN
US9286611077
CUSIP
928661107
Address
13215 Bee Cave Parkway
Phone
646 650 1351
Country
US
Employee
101
IPO Date
Mar 2, 2012
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
VNRX Financial Summary
CIK
0000093314
Exchange
AMEX
Industry
Medical - Diagnostic...
Sector
Healthcare
CUSIP
928661107
ISIN
US9286611077
Country
US
Price
0.68
Beta
1.1
Volume Avg.
271.67k
Market Cap
64.86M
Shares
-
52-Week
0.43-1.23
DCF
-0.37
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.88
P/B
-
Website
https://www.volition.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest VNRX News
It looks like there's no news available.
